Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control studyArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2117092 PMC 바로가기
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variantsSARS-CoV-2 오미크론 변이체에 감염된 중국 참가자의 VV116에 대한 공개, 전향적 코호트 연구Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2078230 PMC 바로가기 [Article Type] Article
The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysisResearch article Published on 2022-12-012022-10-05 Journal: The Lancet Regional Health - Western Pacific [Category] [DOI] 10.1016/j.lanwpc.2022.100569 [Article Type] Research article
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a PartArticle Published on 2022-10-182022-11-15 Journal: Antimicrobial Agents and Chemotherapy [Category] [DOI] 10.1128/aac.00697-22 PMC 바로가기
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritisArticle Published on 2022-10-122022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.960001 PMC 바로가기
A Bivalent Omicron-Containing Booster Vaccine against Covid-19Article Published on 2022-10-062022-11-15 Journal: The New England Journal of Medicine [Category] [DOI] 10.1056/NEJMoa2208343 PMC 바로가기
Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications in the medium and long termArticle Published on 2022-10-062022-11-15 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0268871 PMC 바로가기
Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II studyClinical Trial Published on 2022-10-012022-10-05 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2022.08.007 [Article Type] Clinical Trial
Barotrauma in COVID 19: Incidence, pathophysiology, and effect on prognosisResearch article Published on 2022-10-012022-10-05 Journal: Clinical imaging [Category] [DOI] 10.1016/j.clinimag.2022.06.014 [Article Type] Research article
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)Article Published on 2022-09-272022-11-15 Journal: BMC Medicine [Category] [DOI] 10.1186/s12916-022-02518-7 PMC 바로가기